Polypeptide vaccine and preparation method thereof
A polypeptide vaccine and polypeptide solution technology, which is applied in the direction of pharmaceutical formula, medical preparations with non-active ingredients, medical preparations containing active ingredients, etc., can solve problems such as inflammation or allergic reactions, and affect the specificity of antigenic peptides, achieving significant Effects of immune activity, guaranteed quality, and low production cost
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0032] The preparation method of the above-mentioned polypeptide vaccine comprises the following steps:
[0033] 1) Dissolving the immunoactive peptide to obtain a peptide solution for later use;
[0034] 2) Dissolving the non-protein carrier to obtain a non-protein carrier solution, set aside;
[0035] 3) Add coupling agent to the polypeptide solution or non-protein carrier solution, and mix well;
[0036] 4) Mix the non-protein carrier solution and the polypeptide solution evenly, stir and react, so that the polypeptide is coupled to the non-protein carrier;
[0037] 5) After the reaction is complete, remove the coupling agent that did not participate in the reaction, and purify the coupled polypeptide;
[0038] 6) Adding a medically acceptable adjuvant to the coupled polypeptide to obtain a polypeptide vaccine.
[0039] Preferably, the mass mixing ratio of the polypeptide to the non-protein carrier is 1-100:1.
[0040] Preferably, the mass mixing ratio of the non-protei...
Embodiment 1
[0044] Polypeptide vaccine for porcine blue ear disease and preparation method thereof
[0045] 1. Peptide screening and synthesis
[0046] 1) Screening of peptides
[0047] Predict the epitope of the structural glycoprotein of porcine blue ear virus (PRRSV) by computer analysis software, determine the amino acid sequence of the natural antigen, and then search for the epitopes targeted by the peptide, and select the primary polypeptide sequence.
[0048] The reaction between different polypeptides and porcine PRRS virus antiserum was detected by enzyme-linked method (ELISA), and finally the B cell epitope polypeptides P1~P4 with good reactogenicity and immunogenicity were selected, and their sequences are as follows:
[0049] P1: SHIQLIYNLNC (SEQ ID NO: 1)
[0050] P2: SHIQLIYNLTLCEPL (SEQ ID NO: 2)
[0051] P3: VEKGFKVVFGNVSGIVA (SEQ ID NO: 3)
[0052] P4: RKVYVDIKHQFICADH (SEQ ID NO: 4)
[0053] Using polypeptide to stimulate porcine T cells (IFNγ / ELISPOT) method, ...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


